Exploring Osimertinib And The Flaura Trial
Let's dive into the details surrounding Osimertinib And The Flaura Trial.
- Osimertinib
- First-line
- Dr. Jack West discusses the implications of a positive
- Suresh S. Ramalingam, MD, deputy director of the Winship Cancer Institute and director of the Division of Medical Oncology in the ...
- Gerry Hanna, MBBCh, PhD, MRCP, FRCR, FRANZCR, Trinity College Dublin, Dublin, Ireland, gives an overview of safety data ...
In-Depth Information on Osimertinib And The Flaura Trial
Source: https://www.spreaker.com/user/cancergrace/kimpodcast4 Dr. Chul Kim takes a look at the Suresh Ramalingam, MD, FASCO, of Winship Cancer Institute, Emory University, Atlanta, GA, discusses the final overall survival ... Yi-Long Wu, MD, discusses the data from the Panelists discuss the overall survival analysis of
Dr Suresh Ramalingam speaks to ecancer at ASCO 2024 about results from the
That wraps up our extensive overview of Osimertinib And The Flaura Trial.
